mRNA Vaccines & Therapeutics Market Report

Europe mRNA Vaccines & Therapeutics Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 18, 2019
  • PAGES：197
  • REPORT CODE：GMM329242
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The mRNA Vaccines & Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe mRNA Vaccines & Therapeutics Market Segmentations:

    By Player:

    • BioNTech

    • Intellia Therapeutics

    • MaxCyte

    • PhaseRx

    • Janssen

    • Boehringer Ingelheim

    • RaNa Therapeutics

    • Novartis

    • Ethris

    • CRISPR Therapeutics

    • CureVac

    • Kernal Biologics

    • Precision NanoSystems

    • eTheRNA

    • Argos Therapeutics

    • Sangamo Therapeutics

    • AstraZeneca

    • Bayer

    • GlaxoSmithKline Vaccines

    • ETheRNA immunotherapies

    By Type:

    • In-house mRNA Manufacturing

    • Out-sourced mRNA Manufacturing

    By End-User:

    • Cancer Vaccines

    • Infectious Disease Vaccines

    • In vivo Therapeutics

    • Gene Editing

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines & Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of In-house mRNA Manufacturing from 2014 to 2026

    • 1.3.2 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Out-sourced mRNA Manufacturing from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Cancer Vaccines from 2014 to 2026

    • 1.4.2 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Vaccines from 2014 to 2026

    • 1.4.3 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of In vivo Therapeutics from 2014 to 2026

    • 1.4.4 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Gene Editing from 2014 to 2026

    • 1.4.5 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of mRNA Vaccines & Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of mRNA Vaccines & Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of In-house mRNA Manufacturing

      • 3.4.2 Market Size and Growth Rate of Out-sourced mRNA Manufacturing

    4 Segmentation of mRNA Vaccines & Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of mRNA Vaccines & Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Cancer Vaccines

      • 4.4.2 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Infectious Disease Vaccines

      • 4.4.3 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for In vivo Therapeutics

      • 4.4.4 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Gene Editing

      • 4.4.5 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe mRNA Vaccines & Therapeutics Production Analysis by Top Regions

    • 5.2 Europe mRNA Vaccines & Therapeutics Consumption Analysis by Top Regions

    • 5.3 Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 France mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Circulation of mRNA Vaccines & Therapeutics Market among Top Countries

    • 6.1 Top 5 Export Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany mRNA Vaccines & Therapeutics Landscape Analysis

    • 7.1 Germany mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 7.2 Germany mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    8. UK mRNA Vaccines & Therapeutics Landscape Analysis

    • 8.1 UK mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 8.2 UK mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    9. France mRNA Vaccines & Therapeutics Landscape Analysis

    • 9.1 France mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 9.2 France mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    10. Italy mRNA Vaccines & Therapeutics Landscape Analysis

    • 10.1 Italy mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 10.2 Italy mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    11. Spain mRNA Vaccines & Therapeutics Landscape Analysis

    • 11.1 Spain mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 11.2 Spain mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    12. Poland mRNA Vaccines & Therapeutics Landscape Analysis

    • 12.1 Poland mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 12.2 Poland mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    13. Russia mRNA Vaccines & Therapeutics Landscape Analysis

    • 13.1 Russia mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 13.2 Russia mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    14. Switzerland mRNA Vaccines & Therapeutics Landscape Analysis

    • 14.1 Switzerland mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 14.2 Switzerland mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    15. Turkey mRNA Vaccines & Therapeutics Landscape Analysis

    • 15.1 Turkey mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 15.2 Turkey mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 16.3.1 Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.2 Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.3 Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.4 Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.6 Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 17.3.1 Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 17.3.2 Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 17.3.3 Luxembourg mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 18.3.1 Estonia mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 18.3.2 Latvia mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 18.3.3 Lithuania mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 BioNTech

      • 19.1.1 BioNTech Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Intellia Therapeutics

      • 19.2.1 Intellia Therapeutics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 MaxCyte

      • 19.3.1 MaxCyte Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 PhaseRx

      • 19.4.1 PhaseRx Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Janssen

      • 19.5.1 Janssen Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Boehringer Ingelheim

      • 19.6.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 RaNa Therapeutics

      • 19.7.1 RaNa Therapeutics Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Novartis

      • 19.8.1 Novartis Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Ethris

      • 19.9.1 Ethris Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 CRISPR Therapeutics

      • 19.10.1 CRISPR Therapeutics Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 CureVac

      • 19.11.1 CureVac Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Kernal Biologics

      • 19.12.1 Kernal Biologics Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Precision NanoSystems

      • 19.13.1 Precision NanoSystems Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 eTheRNA

      • 19.14.1 eTheRNA Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Argos Therapeutics

      • 19.15.1 Argos Therapeutics Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Sangamo Therapeutics

      • 19.16.1 Sangamo Therapeutics Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 AstraZeneca

      • 19.17.1 AstraZeneca Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Bayer

      • 19.18.1 Bayer Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 GlaxoSmithKline Vaccines

      • 19.19.1 GlaxoSmithKline Vaccines Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 ETheRNA immunotherapies

      • 19.20.1 ETheRNA immunotherapies Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 87 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of In-house mRNA Manufacturing from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Out-sourced mRNA Manufacturing from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Cancer Vaccines from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Vaccines from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of In vivo Therapeutics from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Gene Editing from 2014 to 2026

    • Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of mRNA Vaccines & Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of mRNA Vaccines & Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of In-house mRNA Manufacturing

    • Figure Market Size and Growth Rate of Out-sourced mRNA Manufacturing

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer Vaccines

    • Figure Market Size and Growth Rate of Infectious Disease Vaccines

    • Figure Market Size and Growth Rate of In vivo Therapeutics

    • Figure Market Size and Growth Rate of Gene Editing

    • Figure Market Size and Growth Rate of Others

    • Table Europe mRNA Vaccines & Therapeutics Production by Major Regions

    • Table Europe mRNA Vaccines & Therapeutics Production Share by Major Regions

    • Figure Europe mRNA Vaccines & Therapeutics Production Share by Major Countries and Regions in 2014

    • Table Europe mRNA Vaccines & Therapeutics Consumption by Major Regions

    • Table Europe mRNA Vaccines & Therapeutics Consumption Share by Major Regions

    • Table Germany mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table UK mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table France mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Italy mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Spain mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Poland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Russia mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Switzerland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Turkey mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Germany mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Germany mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Germany mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of BioNTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

    • Figure Sales and Growth Rate Analysis of BioNTech

    • Figure Revenue and Market Share Analysis of BioNTech

    • Table Product and Service Introduction of BioNTech

    • Table Company Profile and Development Status of Intellia Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics

    • Figure Sales and Growth Rate Analysis of Intellia Therapeutics

    • Figure Revenue and Market Share Analysis of Intellia Therapeutics

    • Table Product and Service Introduction of Intellia Therapeutics

    • Table Company Profile and Development Status of MaxCyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MaxCyte

    • Figure Sales and Growth Rate Analysis of MaxCyte

    • Figure Revenue and Market Share Analysis of MaxCyte

    • Table Product and Service Introduction of MaxCyte

    • Table Company Profile and Development Status of PhaseRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PhaseRx

    • Figure Sales and Growth Rate Analysis of PhaseRx

    • Figure Revenue and Market Share Analysis of PhaseRx

    • Table Product and Service Introduction of PhaseRx

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of RaNa Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RaNa Therapeutics

    • Figure Sales and Growth Rate Analysis of RaNa Therapeutics

    • Figure Revenue and Market Share Analysis of RaNa Therapeutics

    • Table Product and Service Introduction of RaNa Therapeutics

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Ethris

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris

    • Figure Sales and Growth Rate Analysis of Ethris

    • Figure Revenue and Market Share Analysis of Ethris

    • Table Product and Service Introduction of Ethris

    • Table Company Profile and Development Status of CRISPR Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics

    • Figure Sales and Growth Rate Analysis of CRISPR Therapeutics

    • Figure Revenue and Market Share Analysis of CRISPR Therapeutics

    • Table Product and Service Introduction of CRISPR Therapeutics

    • Table Company Profile and Development Status of CureVac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

    • Figure Sales and Growth Rate Analysis of CureVac

    • Figure Revenue and Market Share Analysis of CureVac

    • Table Product and Service Introduction of CureVac

    • Table Company Profile and Development Status of Kernal Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kernal Biologics

    • Figure Sales and Growth Rate Analysis of Kernal Biologics

    • Figure Revenue and Market Share Analysis of Kernal Biologics

    • Table Product and Service Introduction of Kernal Biologics

    • Table Company Profile and Development Status of Precision NanoSystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision NanoSystems

    • Figure Sales and Growth Rate Analysis of Precision NanoSystems

    • Figure Revenue and Market Share Analysis of Precision NanoSystems

    • Table Product and Service Introduction of Precision NanoSystems

    • Table Company Profile and Development Status of eTheRNA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA

    • Figure Sales and Growth Rate Analysis of eTheRNA

    • Figure Revenue and Market Share Analysis of eTheRNA

    • Table Product and Service Introduction of eTheRNA

    • Table Company Profile and Development Status of Argos Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics

    • Figure Sales and Growth Rate Analysis of Argos Therapeutics

    • Figure Revenue and Market Share Analysis of Argos Therapeutics

    • Table Product and Service Introduction of Argos Therapeutics

    • Table Company Profile and Development Status of Sangamo Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics

    • Figure Sales and Growth Rate Analysis of Sangamo Therapeutics

    • Figure Revenue and Market Share Analysis of Sangamo Therapeutics

    • Table Product and Service Introduction of Sangamo Therapeutics

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of GlaxoSmithKline Vaccines

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Vaccines

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Vaccines

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Vaccines

    • Table Product and Service Introduction of GlaxoSmithKline Vaccines

    • Table Company Profile and Development Status of ETheRNA immunotherapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ETheRNA immunotherapies

    • Figure Sales and Growth Rate Analysis of ETheRNA immunotherapies

    • Figure Revenue and Market Share Analysis of ETheRNA immunotherapies

    • Table Product and Service Introduction of ETheRNA immunotherapies

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US